Potent antitumour activity of a new class of tumour-specific killer cells

Nature
S Y ChenX F Huang

Abstract

Two approaches to the antibody-directed targeting of toxic or cytolytic activity and augmentation of cellular immune responses have been explored for tumour immunotherapy, but so far success has been limited. Obstacles facing immunotherapy are the limited accessibility of antibodies or antibody conjugates to solid tumours and the difficulty in obtaining tumour-specific cytotoxic lymphocytes. Here we generate a new class of tumour-specific killer cells by genetically modifying lymphocytes to produce and secrete a targeted toxin against an oncoprotein overexpressed on breast and other tumour cells. The transduced lymphocytes were shown to have potent and selective cytotoxicity to tumours in culture and nude mouse models. The potent in vivo antitumour activity is probably a result of the migration of the lymphocytes to tumours as a targeted toxin carrier, and production and accumulation of the targeted toxins inside tumours as a producer. Our approach, which has features of both antibody-directed and cell-mediated immunotherapy, may have application in a gene therapy context.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J K BatraC R King
Nov 22, 1991·Science·I Pastan, D FitzGerald
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K CulverR M Blaese
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G GrossZ Eshhar
Jul 10, 1987·Science·P P Di FioreS A Aaronson
Jan 1, 1986·Annual Review of Cell Biology·P Walter, V R Lingappa
Nov 20, 1987·Science·E S VitettaJ W Uhr
Mar 1, 1986·Somatic Cell and Molecular Genetics·A D MillerC Buttimore
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·S Y ChenW A Marasco
Jul 1, 1994·Scientific American·R K Jain
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·W A MarascoS Y Chen
Apr 1, 1996·Seminars in Cancer Biology·C R KingI Pastan

❮ Previous
Next ❯

Citations

May 8, 2001·International Journal of Cancer. Journal International Du Cancer·P K SelboK Berg
Sep 25, 2002·Critical Reviews in Oncology/hematology·R S RampaulI O Ellis
Apr 18, 2003·Protein Expression and Purification·Michael StöckerAndreas Engert
Dec 2, 2004·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Larisa Pereboeva, David T Curiel
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·A G YangS Chen
Feb 4, 2010·International Journal of Cancer. Journal International Du Cancer·Chang-chen HuYi-quan Ke
Sep 19, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·P Nguyen van Binh, H T Duc
Mar 1, 1997·Expert Opinion on Investigational Drugs·K J KallenS Rose-John
Jul 26, 2000·Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism·M G CastroP R Lowenstein
Jul 18, 2012·Cancer Treatment Reviews·Lin-Tao JiaAn-Gang Yang
Mar 30, 2011·PloS One·Enfeng WangResham Bhattacharya
Mar 23, 2013·European Journal of Medicinal Chemistry·Raffaella CincinelliNadia Zaffaroni
Feb 5, 1999·Circulation Research·L L Demer, Y Tintut
Nov 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·F ParhamiL L Demer
Dec 16, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·K E WatsonL L Demer
May 29, 1998·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·J P Gorski
May 17, 2011·Cell Biochemistry and Biophysics·Aabgeena Naeem, Naveed Ahmad Fazili
Feb 5, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M S FabbriniA Ceriotti
Jun 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yan-Ming XuAn-Gang Yang
Sep 25, 2017·Gene Therapy·R EggersM J Schmitt

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.